Published Date: 31-Jan-2023
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Craniomaxillofacial Devices Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 9.3% CAGR during the forecast period.
The Metal segment acquired maximum revenue share in the Global Craniomaxillofacial Devices Market by Material in 2021 thereby, achieving a market value of $1,977.1 million by 2028. The growth of the market is supported by characteristics such as lesser corrosiveness, the ability to offer firm support to fractures, comparably lower prices in comparison to bio-absorbable competitors, and better market penetration in comparison to other types of materials. Metals, which are less corrosive than other materials, are used in CMF surgery because they physiologically support the fractures.
The Neurosurgery & ENT segment is showcasing a CAGR of 9.5% during (2022 - 2028). This is because of the rising prevalence of spinal diseases and traumatic injuries that need the treatment of cerebrospinal fluid (CSF) during surgical procedures. Craniotomies are procedures that are performed in order to provide neurosurgeons with improved access to the patient's brain. Craniotomies are performed for the purposes of treating head injuries, brain infections, skull fractures, epilepsy, aneurysms, Parkinson's disease, the pressure that has built up in the brain as a result of a stroke or accident, and to remove blood clots that have formed as a result of a head injury.
The CMF Plate & Screw Fixation segment is leading the Global Craniomaxillofacial Devices Market by Product in 2021 thereby, achieving a market value of $2 billion by 2028. This dominance may be due to the widespread use of the product in a variety of surgical operations, including the removal of tumors, deformity repair, orthognathic surgery, and pediatric surgeries. The market for craniomaxillofacial (CMF) devices and equipment is being propelled forward by the rising need for reconstructive surgery. The ever-increasing popularity of cosmetic treatments among millennials is largely responsible for the rise in demand for reconstructive surgery.
The North America market dominated the Global Craniomaxillofacial Devices Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.8 billion by 2028. The Europe market is exhibiting a CAGR of 9.7% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 11.3% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/craniomaxillofacial-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Stryker Corporation, Johnson & Johnson (DePuy Synthes), Medtronic PLC, B. Braun Melsungen AG, Renishaw PLC, Medartis AG, Zimmer Biomet Holdings, Inc., Xilloc Medical B.V, Synimed, and KLS Martin Group.
Unique Offerings from KBV Research
North America Craniomaxillofacial Devices Market Future Scope & Opportunities 2022-2028
Europe Craniomaxillofacial Devices Market Size & Growth Forecast 2022-2028
Asia Pacific Craniomaxillofacial Devices Market Size, Share & Industry Outlook to 2028
LAMEA Craniomaxillofacial Devices Market Growth, Trends & Forecasts 2022-2028